Departments of 1Obstetrics & Gynaecology, 2Pathology and 3Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry, India *Corresponding Author’s e-mail: keepan_r@yahoo.com تسمم احلمل املبكر مع بيلة بروتينية كلوية كمظهر مبدئي اللتهاب الكلية الذئيب تقرير ثالث حاالت فينيتا اأودوبا، اأني�ض كيبانا�رسيل، نرياجا فيجايان، ديباداَتا با�سو، فري �سينج نيجي abstract: Early onset pre-eclampsia (pre-eclampsia at less than 34 gestational weeks) is a severe form of pre- eclampsia; in addition, some women may also develop nephrotic range proteinuria. De novo diagnosis of lupus nephritis (LN) in pregnancy is challenging as it may present with features similar to commonly occurring pre- eclampsia. We report three cases of early onset pre-eclampsia with nephrotic range proteinuria and subsequent diagnosis of LN at the Women and Children hospital attached to Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India, between 2014 and 2017. These cases highlights the need for further evaluation of the association between nephrotic-range proteinuria and early onset pre-eclampsia. The index of suspicion for underlying LN of these type of cases should be high. Earlier detection of LN will prompt better management that can avert or delay short- and long-term morbidity. Keywords: Lupus Nephritis; Pre-Eclampsia; Nephrotic Syndrome; Proteinuria; Case Reports; India. قد ، ذلك جانب اىل احلمل. ت�سمم من حاد �سكل هو احلمل( من 34 ال�سبوع قبل احلمل املبكرة )ت�سمم البداية ذو احلمل ت�سمم امللخ�ص: ا. الت�سخي�ض اجلديد للتهاب الكلية الذئبي اأثناءاحلمل يعترب حتديا لأنه قد يظهر ت�ساب بع�ض هوؤلء الن�سوة ببيلة بروتينية كلوية اأي�سً ب�سفات مماثلة لت�سمم احلمل الأكرث �سيوعا. نورد هنا ثالث حالت من ت�سمم احلمل املبكر م�سحوبة ببيلة بروتينية كلوية والتي �سخ�ست لحقا كالتهاب كلية ذئبي يف م�ست�سفى الن�ساء والأطفال امللحق مبعهد جواهرلل للدرا�سات العليا يف التعليم الطبي والبحث، بودوت�سريي ، الهند بني الأعوام 2014 و 2017. ت�سلط هذه ال�سل�سلة من احلالت ال�سوء على احلاجة اإىل مزيد من التقييم للعالقة بني البيلة الربوتينية الكلوية وبني ت�سمم احلمل املبكر. يجب اأن يكون موؤ�رس ال�سك بوجود �سمني للتهاب الكلية الذئبي يف مثل هذا النوع من احلالت عاليا. ان الك�سف املبكر عن التهاب الكلية الذئبي �سوف يدفع اإىل رعاية اأف�سل ميكن معها جتنب اأو تاأخري الإعتاللت ذات الآجال الق�سرية والطويلة. الكلمات املفتاحية: التهاب الكلية الذئبي؛ ت�سمم احلمل؛ متالزمة كلوية؛ بيلة بروتينية؛ تقارير حالة؛ الهند. Early Onset Pre-Eclampsia with Nephrotic Range Proteinuria as the Initial Manifestation of Lupus Nephritis Report of three cases Vinita Udupa,1 *Anish Keepanasseril,1 Neeraja Vijayan,1 Debadatta Basu,2 Vir Singh Negi3 Sultan Qaboos University Med J, February 2019, Vol. 19, Iss. 1, pp. e73–76, Epub. 30 May 19 Submitted 23 Oct 18 Revision Req. 12 Dec 18; Revision Recd. 3 Jan 19 Accepted 31 Jan 19 Pre-eclampsia is characterised by abnormal placentation and endothelial dysfunction sec- ondary to an imbalance of angiogenic factors occurring early in pregnancy. Early onset pre-eclampsia that develops before 34 gestational weeks represents a severe form of the hypertensive disorders during preg- nancy. The presence of significant proteinuria is regarded as one of the diagnostic criteria distinguishing pre eclampsia from gestational hypertension.1 Systemic lupus erythematosus (SLE) is a multi-systemic autoimmune disorder affecting mostly women of child-bearing age. Nearly two-thirds of the women affected have lupus nephritis (LN) and usually have nephrotic-range protein- uria (>3.5 g/day) with active urinary sediments.2,3 Pre- eclampsia occurs in 10–15% of pregnant women with SLE and is more frequent in those with LN (20–40%).4,5 Women with SLE are reported to have an increased risk of early onset pre-eclampsia. Owing to the similar presentation of pre-eclampsia and LN, it is possible to overestimate this risk due to misclassification of cases.4 Nephrotic-range proteinuria complicates 0.32% of pregnancies, of which pre-eclampsia contributes to 0.19%.6,7 In women with LN where nephrotic-range proteinuria is a criterion for diagnosis, differentiating new-onset SLE or LN in pregnancy from pre-eclampsia remains a challenge. These cases should be met with a high index of suspicion and require further evaluation with autoantibody screening and a possible renal biopsy for diagnosis.8 We report three female patients who presented with early onset pre-eclampsia and nephrotic- range proteinuria and were subsequently diagnosed with LN. This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License. https://doi.org/10.18295/squmj.2019.19.01.014 case report https://creativecommons.org/licenses/by-nd/4.0/ Early Onset Pre-Eclampsia with Nephrotic Range Proteinuria as the Initial Manifestation of Lupus Nephritis Report of three cases e74 | SQU Medical Journal, February 2019, Volume 19, Issue 1 Case Reports All three cases presented at Women and Children hosp- ital attached to Jawaharlal Institute of Postgraduate Med- ical Education and Research, Puducherry, India, between 2014−2017 with early onset of pre-eclampsia between 26 and 30 gestational weeks. All cases had nephrotic- range proteinuria and hypoalbuminaemia. Urinary sedi- ments or haematuria were not noted and ultrasound examination showed normal sized kidneys at present- ation. None had any clinical symptoms suggestive of any connective tissue disorders. On evaluation, all patients were found to be antinuclear antibody (ANA) positive with low complement levels (C3 and C4). During the antenatal period, all patients were monitored for blood pressure, urine output, renal function and fetal monit- oring with ultrasound biometry and non-stress tests [Table 1]. Labour and delivery details were gathered for the three cases [Table 2]. All information was retrieved from medical records without collecting any identifying details, therefore, ethical approval was not sought. However, all patients signed written informed consent forms. Case One A 26-year-old primigravida woman at 26 gestational weeks presented to the emergency obstetric services in 2014 with a maximum blood pressure of 160/100 mmHg and spot urine protein of 3+; thus, she was diagnosed with early onset pre-eclampsia. She was started on nifedipine 10 mg three times per day. Her laboratory tests revealed raised serum creatinine (1.7 mg/dL) and 24 hour urinary protein of 3,540 mg/day. In view of her rapidly worsening renal function (highest serum creatinine level was 3.4 mg/dL) and nephrotic-range proteinuria, a renal biopsy was performed at 28 gesta- tional weeks which revealed class-IV LN. She was ANA positive and was started on prednisolone (60 mg/day) and hydroxychloroquine (200 mg/day). At the time of delivery, her creatinine levels dropped to 1.4 mg/dL. Labour was induced at 34 gestational weeks in view of the severe early onset pre-eclampsia. She delivered a baby boy weighing 2,100 g with an Apgar score of 9 at 5 minutes. Her post-partum blood pressure returned to normal by the tenth day and her serum creatinine level at discharge was 1.1 mg/dL. Case Two A 30-year-old woman with three previous abortions was referred, to the emergency services in 2015, at 30 gestational weeks with early onset pre-eclampsia. She had a blood pressure of 150/90 mmHg and spot urine protein of 4+ on admission and was on nifedipine 30 mg/day. She was started on prednisolone 40 mg/day in view of suspected LN based on positive ANA and dsDNA results. Her blood pressure remained normal and her creatinine levels were stable (1.2–1.4 mg/dL). She was induced at 33 gestational weeks with prosta- glandin E2 gel and delivered a baby girl weighing 1,900 g with an Apgar score of 9 at 5 minutes. Her blood pressure Table 1: Summary of three cases with early onset pre- eclampsia and lupus nephritis Characteristics Case 1 Case 2 Case 3 Age in years 26 30 31 Parity index G1 G4, A3 G2, PL1 Gestational age at presentation in weeks 26 30 29 24 hour urinary protein in mg/ day 3,540 4,020 3,800 Serum albumin in mg/dL 2.1 1.9 2.3 Highest serum creatinine in mg/dL 3.4 1.9 2.1 Platelet count in × 105/mm3 2.05 2.53 2.37 Other obstetric complication None None IUGR Antibody profile ANA positive ANA and dsDNA positive ANA and dsDNA positive Timing of renal biopsy Antenatal (28 gesta- tional weeks) Postnatal Postnatal Renal biopsy finding Class-IV LN Class-IV–V LN Class-IV LN Treatment received HCQ and prednisolone HCQ and prednisolone HCQ and prednisolone G = gravida; A = abortion; PL = preterm and living; IUGR = intrauterine growth restriction; ANA = antinuclear antibody; dsDNA = double stranded DNA; LN = lupus nephritis; HCQ = hydroxychloroquine. Table 2: Labour and delivery details of three cases with early onset pre-eclampsia and lupus nephritis Variable Case 1 Case 2 Case 3 Gestational age at delivery in weeks* 34 33 31 Neonatal outcome Live born Live born Stillborn Birth weight in g 2,100 1,900 980 Apgar score at 5 minutes 9 9 - Neonatal complications Low birth weight Low birth weight and NICU admission - NICU = neonatal intensive care unit. *All labour was induced and mode of delivery was vaginal. Vinita Udupa, Anish Keepanasseril, Neeraja Vijayan, Debadatta Basu and Vir Singh Negi Case Report | e75 those with active lupus and LN.13,14 Due to a multi- system involvement similar to lupus, pre-eclampsia might represent the initial manifestation of an autoimmune disorder. Studies have found that pregnant women with SLE have worse manifestations than pregnant women without SLE and due to the hormonal changes and the increase in cytokines during pregnancy this disease may only be diagnosed for the first time during pregnancy.9,10 Most women with new-onset SLE are found to have a lower frequency of common symptoms suggestive of lupus at presentation, such as fever, arthritis, arthralgia, alopecia, oral ulcers and/or hypocomplementaemia, compared to those diagnosed in a non-pregnant state.2,3 Thrombocytopaenia is reported to occur in 10–40% of cases of new-onset lupus but in all present cases platelet counts were normal.5 However, more women have nephrotic syndrome when diagnosed during pregnancy making it difficult to differentiate from pre-eclampsia, which complicates pregnancy.2,5 Indications for a renal biopsy in pregnant women include unexplained rapidly progressive renal failure and symptomatic nephrotic syndrome; it may also be used as a guide in managing patients with LN.15 As there is a risk of maternal-fetal morbidity, any procedure is usually deferred until the post-partum period, unless it requires management before delivery. The risk of various complications following a renal biopsy is higher during pregnancy compared to the post-partum period (7% versus 1%).16 The presence of a gravid uterus makes it difficult for patients to lie prone so alternative positions, such as sitting upright or lying in the lateral decubitus position, may be preferred.15,16 In the current case report, due to rapidly deteriorating renal function, a biopsy was performed at 28 gestational weeks in one case, whereas it was deferred until delivery in the other two. Miyamoto et al. found eight out of 11 patients diagnosed with new-onset SLE during pregnancy had pre-eclampsia upon initial presentation, while three dev- eloped pre-eclampsia after SLE was diagnosed.3 All cases except one, who developed SLE post-partum, had pre- eclampsia detected in the third trimester of pregnancy. Termination of pregnancy for treating pre-eclampsia resulted in premature births in six out of seven cases. Renal haemodynamic changes along with the hormonal changes of pregnancy may accelerate the decline in renal function and worsen hypertension and proteinuria, as was seen in the current case report. Unless the index of suspicion is high, this can be misinterpreted as worsening pre-eclampsia resulting in iatrogenic premature birth, especially if no prenatal or early preg- nancy reports of normal renal function are available. Zao et al.’s study on new-onset SLE in pregnancy observed that two-thirds (68.8%) of the patients diagn- was controlled with nifedipine 30 mg/day. In view of positive autoantibody screening, raised creatinine levels (1.9 mg/dL) and nephrotic-range proteinuria, a renal biopsy was done in the postnatal period which was reported as class-IV and -V LN. Her creatinine level at discharge on the fourteenth postnatal day was 1.1 mg/dL. At discharge, she was on prednisolone, hydroxychloro- quine and nifedipine (60, 200 and 30 mg/day, respectively). Case Three A 31-year-old multiparous woman with chronic hyper- tension was admitted to the antenatal wards in 2016, at 29 gestational weeks for evaluation of superimposed pre-eclampsia. She was on alpha-methyldopa 250 mg three times a day and to control her high blood pressure, nifedipine 10 mg three times a day was added. Invest- igations revealed normal liver function, serum creatinine (1.22 mg/dL), platelet count (2.05 × 105/mm3) and a normal peripheral smear. Her 24-hour urine protein excretion was 3,800 mg/day. At 30 gestational weeks and 6 days she developed nausea and vomiting and had a blood pressure of 190/110 mmHg. After consulting a neonatologist, a caesarean section was ruled out due to the neonate’s growth restriction and prematurity. Labour was induced with misoprostol (prostaglandin E1) and resulted in intrapartum stillbirth. Her autoanti- body screen was positive and in view of nephrotic- range proteinuria with persistent renal dysfunction (serum creatinine levels: 1.8–2.1 mg/dL), a renal biopsy was performed in the postnatal period which revealed class-IV LN. Discussion Pregnancy leads to changes in the immune system and hormonal profile to promote immune tolerance to sustain pregnancy. Diagnosis of new onset SLE presenting as LN during pregnancy is challenging as it simulates the commonly occurring pre-eclampsia during this period. Presence of medical disorders, especially those associated with autoimmune pathology or vasculopathy are consid- ered risk factors of pre-eclampsia; recent studies have reported similarities in pathogenesis of pre-eclampsia and SLE.9–11 The elevated levels of interferon-α found in SLE have anti-angiogenic and anti-proliferative properties that lead to endothelial cell dysfunction mimicking the endothelial-milieu as in pre-eclamptic women.12 Similar to pre-eclampsia, angiogenic factors like vasc- ular endothelial growth factor and placental growth factor decrease and levels of anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 increase in Early Onset Pre-Eclampsia with Nephrotic Range Proteinuria as the Initial Manifestation of Lupus Nephritis Report of three cases e76 | SQU Medical Journal, February 2019, Volume 19, Issue 1 osed in pregnancy had LN; this was a much higher rate than among those who were not pregnant.2 Women who developed LN had nephrotic-range proteinuria and low serum albumin levels compared to non-pregnant control cases with SLE.2 All three of the current patients who presented with pre-eclampsia had nephrotic- range proteinuria and serum hypoalbuminaemia. All current patients had autoantibodies present and under- went a renal biopsy according to the American College of Rheumatology guidelines, two cases during the post- natal period and one case during the antenatal period, confirming the diagnosis of LN.8 Conclusion The index of suspicion of underlying LN should be high upon presentation of early-onset pre-eclampsia with nephrotic-range proteinuria and hypoalbuminaemia. Autoantibody screening should be performed and if positive, a renal biopsy may be considered. Early detection of LN would lead to better management that can avert or delay short- and long-term morbidity. References 1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gyne- cologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122:1122–31. https://doi.org/10.1097/01.AOG.00 00437382.03963.88. 2. Zhao C, Zhao J, Huang Y, Wang Z, Wang H, Zhang H, et al. New-onset systemic lupus erythematosus during pregnancy. Clin Rheumatol 2013; 32:815–22. https://doi.org/10.1007/s100 67-013-2180-z. 3. Miyamoto T, Hoshino T, Hayashi N, Oyama R, Okunomiya A, Kitamura S, et al. Preeclampsia as a manifestation of new-on- set systemic lupus erythematosus during pregnancy: A case-based literature review. AJP Rep 2016; 6:e62–7. https://doi.org/10.10 55/s-0035-1566245. 4. Simard JF, Arkema EV, Nguyen C, Svenungsson E, Wikström AK, Palmsten K, et al. Early-onset preeclampsia in lupus pregnancy. Paediatr Perinat Epidemiol 2017; 31:29–36. https://doi.org/10.11 11/ppe.12332. 5. Stanhope TJ, White WM, Moder KG, Smyth A, Garovic VD. Obstetric nephrology: Lupus and lupus nephritis in pregnancy. Clin J Am Soc Nephrol 2012; 7:2089–99. https://doi.org/10.22 15/CJN.12441211. 6. Côté AM, Sauvé N. The management challenges of non- preeclampsia-related nephrotic syndrome in pregnancy. Obstet Med 2011; 4:133–9. https://doi.org/10.1258/om.2011.110001. 7. Brown RA, Kemp GJ, Walkinshaw SA, Howse M. Pregnancies complicated by preeclampsia and non-preeclampsia-related nephrotic range proteinuria. Obstet Med 2013; 6:159–64. https://doi.org/10.1177/1753495X13498382. 8. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guide- lines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012; 64:797–808. https://doi.org/1 0.1002/acr.21664. 9. Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004; 51:989–95. https://doi.org/1 0.1002/art.20837. 10. Cudihy D, Lee RV. The pathophysiology of pre-eclampsia: Current clinical concepts. J Obstet Gynaecol 2009; 29:576–82. https://doi.org/10.1080/01443610903061751. 11. Nanjundan P, Bagga R, Kalra JK, Thakur JS, Raveendran A. Risk factors for early onset severe pre-eclampsia and eclampsia among North Indian women. J Obstet Gynaecol 2011; 31:384–9. https://doi.org/10.3109/01443615.2011.566389. 12. Andrade D, Kim M, Blanco LP, Karumanchi SA, Koo GC, Redecha P, et al. Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol 2015; 67:977–87. https://doi.org/10.1002/art.39029. 13. Rhee JS, Young BC, Rana S. Angiogenic factors and renal disease in pregnancy. Case Rep Obstet Gynecol 2011; 2011:281391. https://doi.org/10.1155/2011/281391. 14. de Jesus GR, de Jesus NR, Levy RA, Klumb EM. The use of angiogenic and antiangiogenic factors in the differential diag- nosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis. Lupus 2014; 23:1299–301. https://doi.org/10. 1177/0961203314529172. 15. Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol 2017; 12:825–35. https://doi.org/10.2215/ CJN.05780616. 16. Piccoli GB, Daidola G, Attini R, Parisi S, Fassio F, Naretto C, et al. Kidney biopsy in pregnancy: Evidence for counselling? A syste- matic narrative review. BJOG 2013; 120:412–27. https://doi.org/10. 1111/1471-0528.12111. https://doi.org/10.1097/01.AOG.0000437382.03963.88 https://doi.org/10.1097/01.AOG.0000437382.03963.88 https://doi.org/10.1007/s10067-013-2180-z https://doi.org/10.1007/s10067-013-2180-z https://doi.org/10.1055/s-0035-1566245 https://doi.org/10.1055/s-0035-1566245 https://doi.org/10.1111/ppe.12332 https://doi.org/10.1111/ppe.12332 https://doi.org/10.2215/CJN.12441211 https://doi.org/10.2215/CJN.12441211 https://doi.org/10.1258/om.2011.110001 https://doi.org/10.1177/1753495X13498382 https://doi.org/10.1002/acr.21664 https://doi.org/10.1002/acr.21664 https://doi.org/10.1002/art.20837 https://doi.org/10.1002/art.20837 https://doi.org/10.1080/01443610903061751 https://doi.org/10.3109/01443615.2011.566389 https://doi.org/10.1002/art.39029 https://doi.org/10.1155/2011/281391 https://doi.org/10.1177/0961203314529172 https://doi.org/10.1177/0961203314529172 https://doi.org/10.2215/CJN.05780616 https://doi.org/10.2215/CJN.05780616 https://doi.org/10.1111/1471-0528.12111 https://doi.org/10.1111/1471-0528.12111